This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teirstein, P. S. Search for Related Content PubMed Articles by Teirstein, P. S.

Unprotected Left Main Intervention

Patient Selection, Operator Technique, and Clinical Outcomes

Division of Cardiology and Interventional Cardiology, Scripps Clinic, La Jolla, California.

^_* Reprint requests and correspondence: Dr. Paul S. Teirstein, Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California 92037. (Email: pteirstein{at}scrippsclinic.com).

In the 1980s, early attempts at balloon angioplasty of the unprotected left main coronary artery (UPLM) were associated with poor early outcomes because of coronary dissection, abrupt closure, and restenosis. Mortality rates as high as 30% at 1 year were reported. In the 1990s, bare-metal stents helped reduce acute complications, but high rates of repeat revascularization (20% to 30%) were observed because of restenosis. In the early 2000s, the introduction of drug-eluting stents (DES), with the promise of vastly reduced rates of restenosis, raised the possibility of improved late outcomes for UPLM patients receiving stents. Although use of DES for UPLM is currently a class III indication in patients who are candidates for coronary artery bypass graft (CABG), many patients are currently undergoing this procedure. Published registries indicate the procedural and in-hospital risks are acceptable and seem to be the same or lower than the procedural risks of CABG. Unprotected left main ostial and midshaft lesions have excellent early and midterm outcomes that will likely (although not yet proven) be similar to those of CABG. Distal left main lesions involving the bifurcation are technically more challenging and associated with a higher rate of late revascularization. Early registry data have not found excess mortality in patients receiving DES for UPLM when compared with historical bypass surgery data, even when the distal bifurcation is stented. However, current follow-up of stented patients is limited to 1 year or less. Over the next few years, the results of randomized trials will expand the evidence base available to clinicians caring for this challenging patient group.

Abbreviations and Acronyms   CABG = coronary artery bypass graft   DES = drug-eluting stent(s)   IVUS = intravascular ultrasound   LAD = left anterior descending artery   PES = paclitaxel-eluting stent(s)   SES = sirolimus-eluting stent(s)   TLR = target lesion revascularization   TVR = target vessel revascularization   UPLM = unprotected left main coronary artery

This article has been cited by other articles:

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				A. C. Weustink, A. F.L. Schinkel, M. van der Ent, and P. J. de Feyter Pre-Procedural Dual Source 64-Slice Computed Tomography in Unprotected Left Main Intervention J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 470 - 471. [Full Text] [PDF]

				P. S. Teirstein Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis Circulation, February 24, 2009; 119(7): 1021 - 1033. [Full Text] [PDF]